THE US Food and Drug Administration has approved the marketing of ClearMate, a new device intended to be used to treat patients suffering from carbon monoxide poisoning.
ClearMate, which consists of a gas mixer, valves, meters, breathing circuits, an oxygen reservoir, a mask and hoses, uses a novel method for quickly removing CO from the body, working to increase a patient's rate of breathing.
Hospital emergency rooms are expected to be the main setting where ClearMate is used.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Mar 19
